N/A
N=87
Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients
Migraine Disorders
Bottom Line
View on ClinicalTrials.gov: NCT03435185 ↗Enrolled (actual)
87
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: Change of Frequency of Headache — 5.3; 7.5 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lidocaine injections (Procedure); Saline injections (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change of Frequency of Headache |
5.3; 7.5 | — |
| PRIMARY Change of Severity of Headache |
5.5; 7.4 | — |
Summary
The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.
Eligibility Criteria
Inclusion Criteria
- Lack of benefits 1 year from preventive treatment or intolerance to their treatments.
- 18 ≥ years old
- Migraine without aura for more than 1 year, minimum of two or more migraine attacks per month.
Exclusion Criteria
- Patients with any chronic illness, medication overuse headache, a history of cranial and cervical surgery
- Allergies to local anesthetics
- Hemorrhagic diathesis
- Alcohol or drug abuse
Data sourced from ClinicalTrials.gov (NCT03435185). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.